Total raised
—
Last: Pre-Seed 2021-01
Stage
Pre-Seed
Founded
2019
Headcount
3
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
MemoryPlus is pioneering an innovative treatment targeting Alzheimer’s-related cognitive decline, leveraging a novel mechanism of action (MOA). Its research is based on groundbreaking work from Prof. Shira Knafo, who discovered that the PTEN protein plays a critical role in memory decline by inhibiting neuronal activity. By disrupting the interaction between PTEN and PDZ domain proteins, the company has the potential to restore memory function.
Funding history · 1 round · — total
2021-01
Pre-Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
alzheimers-diseasepharmaceuticalsbiotechnologytreatments